Rhythm Pharmaceuticals secures up to $750 million term loan led by KKR’s HealthCare Royalty with Blackstone
Bitget2026/11/03 03:00- Rhythm Pharmaceuticals entered a five-year $750 million term-loan facility led by KKR's HealthCare Royalty in partnership with Blackstone.
- The facility includes $500 million committed, with an initial $250 million draw expected at closing on November 6, 2026.
- Another $250 million of committed capital is available through June 30, 2028; an additional $250 million requires mutual agreement.
- Borrowings bear interest at SOFR plus 4.60%, with no scheduled principal amortization before maturity.
- Proceeds will support the amended LG Chem licensing agreement, global commercialization efforts and research and development programs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.
Why Nintendo Stock Is One to Watch Ahead of the Holiday Season
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Crypto prices
More
